Gamida Cell’s Bone Marrow Transplant Alternative Succeeds In Phase III

Young adult woman walking up the stairs with sun sport background.
Gamida Cell's omidubicel is on the path to US FDA submission • Source: Shutterstock

More from Clinical Trials

More from R&D